Galmed Pharmaceuticals Stock Price Patterns

Intrinsic Valuation Low Real High 0.18 3.53 8.94 Details

Naive Forecast Low Next High 0.01 0.70 6.11 Details

1 Analysts Consensus Low Target High 10.92 12.00 13.32 Details

Earnings Estimates (0) Low Projected EPS High -0.58 -0.58 -0.58 Details

Galmed Pharmaceuticals After-Hype Price Density Analysis

Galmed Pharmaceuticals Estimiated After-Hype Price Volatility

Galmed Pharmaceuticals Stock Price Outlook Analysis

Notes

Galmed Pharmaceuticals Hype Timeline

Galmed Pharmaceuticals is currently traded for 0.71. The entity has historical hype elasticity of 0.1, and average elasticity to hype of competition of 0.15. Galmed is expected to increase in value after the next headline, with the price projected to jump to 0.81 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 14.08%, whereas the daily expected return is currently at -0.89%. The volatility of related hype on Galmed Pharmaceuticals is about 3201.18%, with the expected price after the next announcement by competition of 0.86. Galmed Pharmaceuticals currently holds 2.17 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Galmed Pharmaceuticals has a current ratio of 8.31, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Galmed Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next expected press release will be in about 6 days. Check out Galmed Pharmaceuticals Basic Forecasting Models to cross-verify your projections. For information on how to trade Galmed Stock refer to our How to Trade Galmed Stock guide.

Galmed Pharmaceuticals Related Hype Analysis

Galmed Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Galmed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Galmed using various technical indicators. When you analyze Galmed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Galmed Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Galmed Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Galmed Pharmaceuticals based on analysis of Galmed Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.